Multiplex immunoassays analysis of plasma biomarker levels and response to neoadjuvant chemotherapy for locally advanced breast cancer

被引:0
|
作者
Cho, J. H. [1 ]
Park, K. [2 ]
Lee, E. [2 ]
Kim, Y. [1 ]
Park, S. [1 ]
Yoon, S. E. [1 ]
Lee, K. K. [1 ]
Hur, J. Y. [1 ]
Lee, S. K. [3 ]
Lee, J. E. [3 ]
Kim, S. W. [3 ]
Nam, S. J. [3 ]
Yu, J. [3 ]
Kim, J-Y. [1 ]
Jung, H. H. [4 ]
Park, Y. H. [1 ]
机构
[1] Sungkyunkwan Univ, Dept Med, Samsung Med Ctr, Div Hematol Oncol,Sch Med, Seoul, South Korea
[2] Sungkyunkwan Univ, Samsung Genome Inst, Samsung Med Ctr, Sch Med, Seoul, South Korea
[3] Sungkyunkwan Univ, Dept Surg, Samsung Med Ctr, Div Breast Surg,Sch Med, Seoul, South Korea
[4] Sungkyunkwan Univ, Biomed Res Inst, Samsung Med Ctr, Sch Med, Seoul, South Korea
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
275P
引用
收藏
页数:1
相关论文
共 50 条
  • [11] Neoadjuvant chemotherapy for male with locally advanced breast cancer
    Murashko, R.
    Keshabyan, A.
    Zandaryan, A.
    Stepanov, A.
    [J]. BREAST, 2019, 44 : S69 - S69
  • [12] Predictive markers of response to neoadjuvant chemotherapy in locally advanced breast cancer (LAPC)
    Mukherjee, A.
    Shehata, M.
    Sharma, R.
    Rakha, E.
    Ellis, I.
    Ball, G.
    Ball, B. M.
    Chan, S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [13] Response to Neoadjuvant Chemotherapy in Elderly Patients with Locally Advanced Breast Cancer.
    Vanderhaegen, J.
    Wildiers, H.
    Christiaens, M-R
    Smeets, A.
    Leunen, K.
    Neven, P.
    Vergote, I.
    Vanlimbergen, E.
    Weitens, C.
    Janssen, H.
    Moerman, P.
    Brouckaert, O.
    Brouwers, B.
    Paridaens, R.
    [J]. CANCER RESEARCH, 2011, 71
  • [14] Prospective Evaluation of Response Outcomes of Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer
    Ashok, A.
    Sude, Nandkishor Sopanrao
    Rakesh, B. A.
    Karanam, Venkata Pavan Kumar
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (02)
  • [16] Tumour Characteristics Determining Response to Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer
    Turna, Z. Savas
    Ozturk, M. A.
    Tural, D.
    Biricik, F. S.
    Yildiz, O.
    Ozguroglu, M. A.
    Demirelli, F.
    Mandel, N. M.
    Buyukunal, E.
    Serdengecti, S.
    [J]. EUROPEAN JOURNAL OF CANCER, 2011, 47 : S344 - S344
  • [17] Predictors of response to neoadjuvant chemotherapy in women with locally advanced breast cancer.
    Parmar, V
    Nadkarni, M. S.
    Hawaldar, R.
    Shet, T.
    Nair, R.
    Gupta, S.
    Chinoy, R.
    Badwe, R.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2007, 106 : S172 - S173
  • [18] Circulating T cells and response to neoadjuvant chemotherapy in locally advanced breast cancer
    do Moura, J. F. P.
    Torres, L. C.
    Lima, V. C. C.
    Salles, A.
    [J]. ANNALS OF ONCOLOGY, 2021, 32 : S1214 - S1214
  • [19] The influence of breast cancer subtypes on response to anthracycline neoadjuvant chemotherapy in locally advanced breast cancer patients
    Susnjar, S.
    Stamatovic, L.
    Gavrilovic, D.
    Minic, I.
    Ursulovic, T.
    [J]. BREAST, 2017, 32 : S81 - S82
  • [20] Serum levels of tumor necrosis factor alpha correlate with response to neoadjuvant chemotherapy in locally advanced breast cancer
    Berberoglu, U
    Yildirim, E
    Celen, O
    [J]. INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2004, 19 (02): : 130 - 134